Sodium Citrate for Health & Longevity - Quick Reference Sheet

Sodium Citrate for Health & Longevity

Created on 07/09/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Sodium citrate is a cheap salt the body turns into a base, lowering acidity in blood and urine. It cuts calcium kidney stone recurrence, though a potassium form is often better. As an exercise aid its benefit is small and mixed. Its heavy salt load can upset the stomach, raise blood pressure, and is unsafe with kidney or heart disease. (Full Review)

Protocol

Ergogenic Dose
500 mg/kg
In capsules, 120–180 min before high-intensity exercise
Stone Prevention
30–60 mEq/day citrate
Oral solution in divided doses, titrated to urine pH 6.0–7.0
Delivery
Split or enteric capsules
Split over 30–60 min to reduce GI symptoms
Time to effect
Blood Alkalosis
1–3 hours
Peaks 2–3 hours post-dose
Urinary Changes
Within hours
Measurable urinary-chemistry shifts
Stone Prevention
Months
Accrues over months of consistent use

Benefits

Contraindications
  • Severe chronic kidney disease (eGFR <30)
  • Decompensated heart failure (NYHA III–IV)
  • Uncontrolled hypertension
  • Metabolic alkalosis or high blood sodium
  • Active urea-splitting urinary infection
Key Interactions
  • Aluminum-containing antacids and sucralfate (e.g., aluminum hydroxide, sucralfate)
  • Lithium
  • Weak-acid drugs (e.g., high-dose aspirin, salicylates, methotrexate)
  • Weak-base drugs (e.g., quinidine, flecainide, amphetamines, ephedrine, memantine)
  • Potassium-retaining drugs (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics)
  • Sodium-containing effervescent analgesics and antacids
  • Other alkalinizing/buffering supplements (e.g., sodium bicarbonate, potassium citrate, potassium bicarbonate)

Risk & Side Effects

  • High: Gastrointestinal distress; sodium overload and fluid retention
  • Medium: Metabolic alkalosis; blood pressure elevation
  • Low: Increased aluminum absorption; altered renal clearance of other drugs
  • Speculative: Long-term cardiovascular and renal sodium effects

Monitoring

Marker Target Why
Serum bicarbonate (CO₂) 24–28 mmol/L Tracks acid-base status and buffering response
Blood pressure <120/80 mmHg Detects sodium-driven rises
Serum sodium 135–142 mmol/L Flags sodium overload or high blood sodium
Serum potassium 4.0–4.5 mmol/L Baseline safety before alkali therapy
eGFR / creatinine eGFR >90 mL/min/1.73 m² Confirms kidneys can clear the sodium and citrate load
Urinary pH 6.0–6.5 (stone prevention) Confirms alkalinization without overshooting
24-hour urinary citrate >640 mg/day Confirms correction of low urinary citrate

Cadence: Recheck labs and blood pressure 4–8 weeks after starting or changing dose, then every 6–12 months (more often in older adults or reduced kidney function); stone formers reassess 24-hour urine chemistry at 8–12 weeks.

Qualitative Assessment

  • Perceived exertion and fatigue during target high-intensity sessions
  • Gastrointestinal comfort after dosing (nausea, bloating, loose stools)
  • Frequency of stone symptoms or passage in stone formers
  • General energy, thirst, and any swelling that could signal fluid retention